» Articles » PMID: 16189192

Moderate Zinc Deficiency Influences Arterial Blood Pressure and Vascular Nitric Oxide Pathway in Growing Rats

Overview
Journal Pediatr Res
Specialties Biology
Pediatrics
Date 2005 Sep 29
PMID 16189192
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

There is an increasing interest in the involvement of trace elements such as zinc in the pathogenesis of cardiovascular diseases. This study was designed to examine whether moderate zinc deficiency during growth influences blood pressure (BP) and vascular nitric oxide (NO) pathway. Three-week-old weaned male Wistar rats were randomly divided into two dietary groups and fed either a moderately zinc-deficient diet (zinc content 9 mg/kg; n = 12) or a control diet (zinc content 30 mg/kg; n = 12) for 60 d. The following were measured: systolic BP, nitrates and nitrites urinary excretion, urinary chemiluminescence intensity, NADPH-diaphorase activity in the thoracic aorta and intestinal arterioles, and NO synthase (NOS) catalytic activity using L-[U14C]-arginine as substrate in the thoracic aorta. Zinc deficiency during growth induced an increase in BP from day 30 of the experimental period, leading to hypertension on day 60. Animals that were fed the zinc-deficient diet had lower urinary excretion levels of nitrates and nitrites and higher intensity of spontaneous luminescence on day 60. At the end of the experiment, zinc-deficient rats showed decreased NADPH diaphorase activity in endothelium and smooth muscle of the thoracic aorta and intestinal arterioles and decreased activity of NOS in thoracic aortic tissue. An imbalance in zinc bioavailability during postnatal and growing periods may be may be a risk factor in development of cardiovascular alterations in adult life. The mechanisms involved may include an impaired vascular NO system as a result of decreased NOS activity and higher systemic oxidative stress.

Citing Articles

The adverse association of animal zinc intake with cardio-cerebrovascular and metabolic risk factors.

Zou S, Jiang B, Wan R, Huang Y Int J Cardiol Cardiovasc Risk Prev. 2024; 20:200231.

PMID: 38179184 PMC: 10765292. DOI: 10.1016/j.ijcrp.2023.200231.


Investigating the Role of Zinc in Atherosclerosis: A Review.

Shen T, Zhao Q, Luo Y, Wang T Biomolecules. 2022; 12(10).

PMID: 36291566 PMC: 9599385. DOI: 10.3390/biom12101358.


Impact of Zinc Deficiency During Prenatal and/or Postnatal Life on Cardiovascular and Metabolic Diseases: Experimental and Clinical Evidence.

Mendes Garrido Abregu F, Caniffi C, Arranz C, Tomat A Adv Nutr. 2022; 13(3):833-845.

PMID: 35167660 PMC: 9156367. DOI: 10.1093/advances/nmac012.


Zinc drives vasorelaxation by acting in sensory nerves, endothelium and smooth muscle.

Betrie A, Brock J, Harraz O, Bush A, He G, Nelson M Nat Commun. 2021; 12(1):3296.

PMID: 34075043 PMC: 8169932. DOI: 10.1038/s41467-021-23198-6.


Effects of Dose and Duration of Zinc Interventions on Risk Factors for Type 2 Diabetes and Cardiovascular Disease: A Systematic Review and Meta-Analysis.

Pompano L, Boy E Adv Nutr. 2020; 12(1):141-160.

PMID: 32722790 PMC: 7850144. DOI: 10.1093/advances/nmaa087.